Download
journal.pone.0247951.pdf 400,45KB
WeightNameValue
1000 Titel
  • Understanding the impact of the SARS-COV-2 pandemic on hospitalized patients with substance use disorder
1000 Autor/in
  1. King, Caroline |
  2. Vega, Taylor |
  3. Button, Dana |
  4. Nicolaidis, Christina |
  5. Gregg, Jessica |
  6. Englander, Honora |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-02-26
1000 Erschienen in
1000 Quellenangabe
  • 16(2):e0247951
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1371/journal.pone.0247951 |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • BACKGROUND: The SARS-COV-2 pandemic rapidly shifted dynamics around hospitalization for many communities. This study aimed to evaluate how the pandemic altered the experience of healthcare, acute illness, and care transitions among hospitalized patients with substance use disorder (SUD). METHODS: We performed a qualitative study at an academic medical center in Portland, Oregon, in Spring 2020. We conducted semi-structured interviews, and conducted a thematic analysis, using an inductive approach, at a semantic level. RESULTS: We enrolled 27 participants, and identified four main themes: 1) shuttered community resources threatened patients’ basic survival adaptations; 2) changes in outpatient care increased reliance on hospitals as safety nets; 3) hospital policy changes made staying in the hospital harder than usual; and, 4) care transitions out of the hospital were highly uncertain. DISCUSSION: Hospitalized adults with SUD were further marginalized during the SARS-COV-2 pandemic. Systems must address the needs of marginalized patients in future disruptive events.
1000 Sacherschließung
lokal Oregon
gnd 1206347392 COVID-19
lokal Hospitals
lokal Opioids
lokal Outpatients
lokal SARS-CoV-2
lokal Drug addiction
lokal Pandemics
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-9913-6340|https://frl.publisso.de/adhoc/uri/VmVnYSwgVGF5bG9y|https://orcid.org/0000-0002-8373-1444|https://frl.publisso.de/adhoc/uri/Tmljb2xhaWRpcywgQ2hyaXN0aW5h|https://frl.publisso.de/adhoc/uri/R3JlZ2csIEplc3NpY2E=|https://orcid.org/0000-0003-1863-2041
1000 Label
1000 Förderer
  1. National Institute on Drug Abuse |
  2. Oregon Clinical and Translational Research Institute |
  3. National Center for Research Resources |
  4. National Institutes of Health |
  5. National Center for Advancing Translational Sciences |
1000 Fördernummer
  1. UG1DA015815/ R01DA037441
  2. -
  3. UL1TR002369
  4. -
  5. TL1TR002371
1000 Förderprogramm
  1. -
  2. -
  3. -
  4. Roadmap for Medical Research
  5. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer National Institute on Drug Abuse |
    1000 Förderprogramm -
    1000 Fördernummer UG1DA015815/ R01DA037441
  2. 1000 joinedFunding-child
    1000 Förderer Oregon Clinical and Translational Research Institute |
    1000 Förderprogramm -
    1000 Fördernummer -
  3. 1000 joinedFunding-child
    1000 Förderer National Center for Research Resources |
    1000 Förderprogramm -
    1000 Fördernummer UL1TR002369
  4. 1000 joinedFunding-child
    1000 Förderer National Institutes of Health |
    1000 Förderprogramm Roadmap for Medical Research
    1000 Fördernummer -
  5. 1000 joinedFunding-child
    1000 Förderer National Center for Advancing Translational Sciences |
    1000 Förderprogramm -
    1000 Fördernummer TL1TR002371
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6425895.rdf
1000 Erstellt am 2021-03-02T14:31:39.102+0100
1000 Erstellt von 122
1000 beschreibt frl:6425895
1000 Bearbeitet von 122
1000 Zuletzt bearbeitet Tue Mar 02 14:32:53 CET 2021
1000 Objekt bearb. Tue Mar 02 14:32:37 CET 2021
1000 Vgl. frl:6425895
1000 Oai Id
  1. oai:frl.publisso.de:frl:6425895 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source